1133-42-2,
1-Methyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione,
1-methyl-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione,
1-methyl-3,4-dihydro-1,4-benzodiazepine-2,5-dione,
1H-1,4-Benzodiazepine-2,5-dione, 3,4-dihydro-1-methyl-,
1-methyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-2,5-dione,
1-methyl-3H,4H-benzo[f]1,4-diazaperhydroepine-2,5-dione,
AC1MSO6R,
AC1Q3Z4K,
SCHEMBL1364964,
CTK0G1273,
DTXSID30393659,
MUESRUHFMTYDIT-UHFFFAOYSA-N,
ALBB-017168,
KS-00001AG7,
2280AA,
ANW-71219,
BBL012290,
MFCD07492626,
SBB082924,
STK803153,
ZINC11919322,
AKOS002676002,
MCULE-8939953628,
AJ-60440,
AB0158292,
AB1008888,
TC-159964,
CS-0037043,
FT-0684303,
ST45175074,
EN300-68193,
Y-3127,
3,4-dihydro-1-methyl-1H-1,4-benzodiazepin-2,5-dione,
Z1263602401,
1-Methyl-3,4-dihydro-1H-benzo[e][1,4]diazapine-2,5-dione,
InChI=1/C10H10N2O2/c1-12-8-5-3-2-4-7(8)10(14)11-6-9(12)13/h2-5H,6H2,1H3,(H,11,14,
null,
C10H10N2O2,
CID3562387,
2-methyl-2,5-diazabicyclo[5.4.0]undeca-7,9,11-triene-3,6-dione,